New Merck-funded study on monthly HIV PrEP
grant
New industry-funded study: Monthly HIV Pre-Exposure Prophylaxis Preferences among U.S. Men Who Have Sex with Men (Merck & Co.). Modeling the population-impact of a monthly HIV PrEP formulation within the daily oral and injectable landscape.